v3.26.1
CONDENSED CONSOLIDATED INTERIM STATEMENTS OF COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Total revenues $ 5,584 $ 6,752
Total cost of revenues 2,384 2,870
Gross profit 3,200 3,882
Operating expenses:    
Research and development 2,385 4,108
Sales and marketing 4,898 5,873
General and administrative 3,226 3,310
Total operating expenses 10,509 13,291
Operating loss 7,309 9,409
Interest expenses 1,149  
Other financial income, net (266) (204)
Total financial expenses (income), net 883 (204)
Loss before taxes 8,192 9,205
Income tax (benefit) 57 22
Net loss 8,249 9,227
Deemed dividend   4,839
Net loss attributable to common shareholders $ 8,249 $ 14,066
Net loss per share:    
Basic net loss per share of common stock (in dollars per share) $ 1.25 $ 2.87
Diluted net loss per share of common stock (in dollars per share) $ 1.25 $ 2.87
Weighted average number of common stock used in computing basic net loss per share (in shares) 6,582,297 2,368,516
Weighted average number of common stock used in computing diluted net loss per share (in shares) 6,582,297 2,368,516
Services    
Total revenues $ 2,826 $ 4,875
Total cost of revenues 563 865
Consumer hardware    
Total revenues 2,758 1,877
Total cost of revenues 1,644 1,130
Amortization of acquired intangible assets    
Total cost of revenues $ 177 $ 875